Unum Therapeutics, Inc.

Home » Unum Therapeutics, Inc.

IPO

Unum Therapeutics, Inc.

We are a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products designed to harness the power of a patient’s immune system to cure cancer

Symbol

UNUM

Price Range
$12.00 - $12.00

Final Shares
5,770,000

Anticipated Date
TBD

Underwriters
Morgan Stanley, Cowen, Wedbush Pacgrow

To view the prospectus for Unum Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253